Pages that link to "Q37285357"
Jump to navigation
Jump to search
The following pages link to Extended-release Trazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Study (Q37285357):
Displaying 11 items.
- Rediscovering trazodone for the treatment of major depressive disorder (Q34314280) (← links)
- Non-tricyclic and Non-selective Serotonin Reuptake Inhibitor Antidepressants and Recurrent Falls in Frail Older Women (Q37470696) (← links)
- Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropout (Q37503551) (← links)
- What Is the Role of Sedating Antidepressants, Antipsychotics, and Anticonvulsants in the Management of Insomnia? (Q38038079) (← links)
- Serotonin and beyond: therapeutics for major depression (Q38084600) (← links)
- Assessment and management of sexual dysfunction in the context of depression (Q47653061) (← links)
- Electrophysiological impact of trazodone on the dopamine and norepinephrine systems in the rat brain (Q48788715) (← links)
- Oleptro™ (trazodone hydrochloride) extended-release tablets (Q83693540) (← links)
- Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials (Q89779290) (← links)
- Dual inhibitory action of trazodone on dorsal raphe serotonergic neurons through 5-HT1A receptor partial agonism and α1-adrenoceptor antagonism (Q90306268) (← links)
- A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder (Q92878884) (← links)